All PlansPrior AuthMedium impact

Newsletter Vol. 9, No. 11

Q: Who is affected by this change?

This affects New Jersey Medicaid Pulmonology, Allergy & Immunology, Family Medicine, Internal Medicine, Pediatrics providers in NJ on All Plans plans.

New Jersey Medicaid·NJ · Pulmonology, Allergy & Immunology, Family Medicine +2 more·Provider Notice

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

New policy implements Prior Duration of Use Review (PDUR) monitoring for pharmaceutical inhalers, which will likely require additional documentation or authorization steps for inhaler prescriptions and related billing.

Action Required

Action needed

Immediately: Review the full Newsletter Vol. 9, No. 11 document at the provided URL to understand specific PDUR monitoring requirements for pharmaceutical inhalers. Billing team should identify what additional documentation or prior authorization steps may be required for inhaler-related claims and update workflows accordingly.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Pulmonology Allergy & Immunology Family Medicine Internal Medicine Pediatrics